title: Is splenectomy a contraindication for patients with myelodysplastic syndromes complicated by splenomegaly?
authors.forename: Ryo
authors.initials: R
authors.lastname: Uchida
authors.forename: Sonoko
authors.initials: S
authors.lastname: Nakano
authors.forename: Kyoko
authors.initials: K
authors.lastname: Namura
authors.forename: Noriko
authors.initials: N
authors.lastname: Yamada
authors.forename: Shin-Ichi
authors.initials: S
authors.lastname: Fuchida
authors.forename: Akira
authors.initials: A
authors.lastname: Okano
authors.forename: Masashi
authors.initials: M
authors.lastname: Okamoto
authors.forename: Naoya
authors.initials: N
authors.lastname: Ochiai
authors.forename: Chihiro
authors.initials: C
authors.lastname: Shimazaki
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D004417:Dyspnea / Q000150:complications / Q000601:surgery*; D005260:Female; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000150:complications / Q000601:surgery*; D013156:Splenectomy / Q000009:adverse effects; D013163:Splenomegaly / Q000209:etiology / Q000601:surgery*